| Gjertsen BT
[In Process Citation] [Journal Article]
Tidsskr Nor Laegeforen 2009 Sep 24; 129(18):1881-2.
Full Citation | Find Related Articles |
| Kildahl-Andersen O, Holte J, Stalsberg H
[50-year-old woman with elevated haemoglobin and iron deficiency.] [English Abstract, Journal Article]
Tidsskr Nor Laegeforen 2009 Sep 24; 129(18):1878-81.
Abstract | Full Citation |
| Sharman JE, Brown J, Holland DJ, et al.
Influence of Altered Blood Rheology on Ventricular-Vascular Response to Exercise. [JOURNAL ARTICLE]
Hypertension 2009 Aug 31.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Veneri D, Capuzzo E, de Matteis G, et al.
Comparison of JAK2V617F mutation assessment employing different molecular diagnostic techniques. [Journal Article]
Blood Transfus 2009 Jul; 7(3):204-9.
Abstract | Full Citation |
| Hussein K, Bock O, Theophile K, et al.
JAK2(V617F) allele burden discriminates essential thrombocythaemia from a subset of pre-fibrotic stage primary myelofibrosis. [JOURNAL ARTICLE]
Exp Hematol 2009 Jul 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Wang X, Leblanc A, Gruenstein S, et al.
Clonal Analyses Define the Relationships between Chromosomal Abnormalities and JAK2V617F in Patients with Ph-negative Myeloproliferative Neoplasms* [JOURNAL ARTICLE]
Exp Hematol 2009 Jul 14.
Abstract | Full Citation | Find Related Articles |
| Alvarez-Larrán A, Bellosillo B, Martínez-Avilés L, et al.
Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients. [JOURNAL ARTICLE]
Br J Haematol 2009 Jul 8.
Abstract | Full Citation | Find Related Articles |
| Garber K
JAK2 inhibitors: not the next imatinib but researchers see other possibilities. [News]
J Natl Cancer Inst 2009 Jul 15; 101(14):980-2.
Full Citation | Publisher Full Text | Find Related Articles |
| Carobbio A, Finazzi G, Antonioli E, et al.
JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia vera. [JOURNAL ARTICLE]
Exp Hematol 2009 Jun 23.
Abstract | Full Citation | Find Related Articles |
| Mesa RA, Tefferi A
Emerging drugs for the therapy of primary and post essential thrombocythemia, post polycythemia vera myelofibrosis. [JOURNAL ARTICLE]
Expert Opin Emerg Drugs 2009 Jun 24.
Abstract | Full Citation | Find Related Articles |
  |
